Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug
|
Luke Timmerman |
09/29/09 |
San Diego
|
|
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
06/11/09 |
San Diego
|
|
Amylin Founder Ted Greene, In Exclusive Interview, Upbeat About Outcome of Proxy Battle
|
Bruce V. Bigelow |
06/02/09 |
San Diego
|
|
Vical Developing Vaccine for Swine Flu, Acadia’s Stock Almost Doubles on Biovail Deal, Qualcomm Launches Business Plan Contest, & Other San Diego BizTech News
|
Bruce V. Bigelow |
05/11/09 |
San Diego
|
|
Diabetes Drug Application May Be New Factor in Amylin Proxy Battle
|
Juha-Pekka Tikka |
05/05/09 |
San Diego
|
|
Amylin Braces for Proxy Battle Amid Flurry of Filings
|
Bruce V. Bigelow |
04/09/09 |
San Diego
|
|
Amylin Shares Soar as Diabetes Drug Catches a Break From FDA
|
Luke Timmerman |
12/11/08 |
San Diego
|
|
Biotech Survival Index: Cash Woes Creeping Up on San Diego Life Sciences Companies
|
Luke Timmerman |
11/18/08 |
San Diego
|
|
Aileron Develops New Class of Drugs To Go Where None Could Before
|
Luke Timmerman |
11/07/08 |
Boston
|
|
Amylin, Alkermes Shares Plunge On Possible FDA Delays
|
Luke Timmerman |
11/04/08 |
San Diego
|
|
Amylin Shareholder Floats Idea of Selling Company
|
Luke Timmerman |
11/04/08 |
San Diego
|
|
Amylin Gets $125M from Eli Lilly To Make Once-Weekly Diabetes Drug
|
Luke Timmerman |
10/21/08 |
San Diego
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
